News Digest / Lukas Schmidt

Author: Lukas Schmidt

11:03am, Tuesday, Nov 11, 2025
Quoin Pharmaceuticals (NASDAQ:QNRX) stock surges 66% following successful achievement of target rapamycin concentrations in new topical formulations, setting stage for clinical trials in 2026.